SCHEDULE 13G/A: BlackRock Discloses 3.7% Passive Stake in Fractyl Health, Inc.
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.7% beneficial ownership stake in Fractyl Health, Inc. as of March 31, 2025, held for ordinary course investment purposes.
Summary
- BlackRock, Inc. reported beneficial ownership of 1,790,026 shares of Fractyl Health, Inc. Common Stock.
- This ownership represents 3.7% of the total outstanding shares of the class of securities.
- BlackRock holds sole voting power over 1,772,896 shares and sole dispositive power over 1,790,026 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Fractyl Health, Inc.
- The filing is an Amendment No. 1 to a previously filed Schedule 13G.
- BlackRock's reporting business units, including BlackRock Advisors, LLC, BlackRock Financial Management, Inc., BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, and BlackRock Investment Management, LLC, contribute to the aggregate beneficial ownership.
Sentiment
Score: 5
Explanation: Neutral. This is a routine disclosure of passive ownership by a large institutional investor, indicating a standard investment position without implying positive or negative sentiment about the issuer's performance or future prospects.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Fractyl Health, Inc.'s business or financial performance.
Industry Context
This filing is a routine disclosure by a major institutional asset manager, BlackRock, Inc., regarding its passive investment stake in Fractyl Health, Inc. It reflects standard portfolio management activities and does not provide broader industry analysis or trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Authorized Signatories for SEC Filings | Previous list of attorneys-in-fact (from April 30, 2023 Power of Attorney) | Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg, Brenda Schulz | 2025-01-21 | Issuance of a new Power of Attorney, revoking the prior one, to update the list of individuals authorized to execute SEC filings and other regulatory documents on behalf of BlackRock, Inc. and its affiliates. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. issued a new Power of Attorney, effective January 21, 2025, authorizing specific individuals to execute SEC filings and other regulatory documents on its behalf and on behalf of its direct and indirect subsidiaries and affiliates. This new Power of Attorney expressly revokes the previous one dated April 30, 2023. | 2025-01-21 | Streamlines the process for BlackRock's authorized individuals to comply with ownership and control-person reporting requirements, ensuring efficient and legally compliant filings for the firm and its various business units. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake, which can offer a degree of confidence in the company's stock liquidity and institutional interest.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of the previous Power of Attorney that was expressly revoked. |
| 2025-01-21 | Effective date of the new Power of Attorney for BlackRock, Inc. authorized signatories. |
| 2025-03-31 | Date of the event which requires the filing of this Schedule 13G statement. |
| 2025-04-23 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Fractyl Health, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, SEC Filing, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.